Multilevel capabilities with strategic oversight and integrity. Seamless compliant integration with crossfunctional divisions hallmarked by inclusive communication style. Launch, lifecycle, IST assessment and management, KOL management and collaboration, creation of patient-facing and peer-to-peer medical education, publication strategy and planning, advisory board oversight and development, broad educational foundation from Dartmouth Medical School seeding innovation for new indication development.

Senior MSL West - Intrathecal Therapy for Chronic Pain (Orphan Drug)

Senior MSL West: WA, OR, HI, CA, ID, UT, CO, NV, AZ, NM

Addictive Disorders, CNS Specialty

Histopathology, classical and immunoassay-based

Start-up company (<100 employees) beginning with 3 Divisions: Performance Materials, Life Sciences, Power and Energy Systems. • Director-level position operating all drug development, IP, and regulatory processes. • Wrote FDA documentation for drug compounds with cross-disciplinary team members. • Internal medical expert. Led all medical communications, including FDA and executive board presentations and public knowledge on website. Identified KOLs and mediated interactions with clinical and scientific staff. • Participated in nanotechnology symposia that included nanoparticle pulmonary interventions, chemotherapeutics, and biotherapeutics such as albumin-constructed particles. • Educated all sales staff to potential renal drug actions, contraindications, and therapeutic use.• Coordinated drug development activities with major partners. • Initiated preliminary toxicity study for other Divisional compounds and performed tissue analyses. Noted accomplishments: Following presentation, FDA favorably reversed decision. New intellectual property (drug application) and presentation resulted in multimillion dollar sale of compounds. Assisted with clinical trial organization for new drugs.

Directed research activities (4 technicians) and maintained financials for two grants (NIH and VA) totaling $3 million dollars. Designed, acquired, and analyzed in vivo nociception studies and resulting histopathology. Instructed courses in neuroanatomy, neuropathology, neuroimmunology, and neurodegradation for medical students and medical residents.Responsible for initiating work into the neuroimmunological basis of pain. First researcher to target TNF for alleviation of pain-states caused by neuropathology.AWARDS:Merit Review Entry Program